Cargando…

Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus

INTRODUCTION: Insulin has shown antioxidation and cytoprotective effects to decrease heart ischemia/reperfusion injury (HI/RI) in diabetes mellitus (DM), but the role of insulin/poly(ethylene glycol)-carboxymethyl chitosan (PEG-CMCS) on HI/RI in DM is not known. This research explored whether insuli...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Fei, Liu, Suhuan, Yan, Bing, Li, Xuejun, Ruan, Shiwei, Yang, Shuyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922236/
https://www.ncbi.nlm.nih.gov/pubmed/29719397
http://dx.doi.org/10.2147/IJN.S160848
_version_ 1783318166830579712
author Tong, Fei
Liu, Suhuan
Yan, Bing
Li, Xuejun
Ruan, Shiwei
Yang, Shuyu
author_facet Tong, Fei
Liu, Suhuan
Yan, Bing
Li, Xuejun
Ruan, Shiwei
Yang, Shuyu
author_sort Tong, Fei
collection PubMed
description INTRODUCTION: Insulin has shown antioxidation and cytoprotective effects to decrease heart ischemia/reperfusion injury (HI/RI) in diabetes mellitus (DM), but the role of insulin/poly(ethylene glycol)-carboxymethyl chitosan (PEG-CMCS) on HI/RI in DM is not known. This research explored whether insulin/PEG-CMCS revealed a protective effect on HI/RI in DM through ornithine decarboxylase (ODC)/polyamine systems. MATERIALS AND METHODS: Diabetes was induced via streptozotocin (STZ) in Sprague Dawley (SD) rats, which suffered from HI via blocking the left circumflex artery for 45 minutes, followed by 2 hours of reperfusion. α-Difluoromethylornithine-ethylglyoxal bis (guanylhydrazone) (DFMO-EGBG) and insulin/PEG-CMCS were administered to diabetic rats to explore their roles on severity of HI/RI. RESULTS: Insulin could be fleetly and efficiently loaded via the nanocarrier PEG-CMCS at pH =6, showing efficient loading and stable release. In addition, insulin/PEG-CMCS showed significant hypoglycemic activity in diabetic rats. On the other hand, ischemia/reperfusion obviously augmented the contents of creatine kinase (CK), lactic dehydrogenase (LDH), putrescine (Pu), myocardial infarct size, and NF-κB and spermidine/spermine N′-acetyltransferase (SSAT) expressions and decreased the levels of spermine (Sp), polyamine pools (PAs), heart rate (HR), coronary blood flow (CF), left ventricular developed pressure (LVDP), and ODC expression, compared with Sham. Administration of insulin and insulin/PEG-CMCS both reduced the contents of CK, LDH, Pu, myocardial infarct size, and NF-κB and SSAT expressions and increased the levels of Sp, PAs, HR, CF, LVDP, and ODC expression, while insulin/PEG-CMCS significantly indicated the protective results, and DFMO-EGBG showed the opposite effects. CONCLUSION: The research showed that insulin/PEG-CMCS could play a protective effect on HR/RI in diabetic rats via its antioxidative, antiapoptotic, and anti-inflammatory roles and modulating ODC/polyamine systems.
format Online
Article
Text
id pubmed-5922236
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-59222362018-05-01 Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus Tong, Fei Liu, Suhuan Yan, Bing Li, Xuejun Ruan, Shiwei Yang, Shuyu Int J Nanomedicine Original Research INTRODUCTION: Insulin has shown antioxidation and cytoprotective effects to decrease heart ischemia/reperfusion injury (HI/RI) in diabetes mellitus (DM), but the role of insulin/poly(ethylene glycol)-carboxymethyl chitosan (PEG-CMCS) on HI/RI in DM is not known. This research explored whether insulin/PEG-CMCS revealed a protective effect on HI/RI in DM through ornithine decarboxylase (ODC)/polyamine systems. MATERIALS AND METHODS: Diabetes was induced via streptozotocin (STZ) in Sprague Dawley (SD) rats, which suffered from HI via blocking the left circumflex artery for 45 minutes, followed by 2 hours of reperfusion. α-Difluoromethylornithine-ethylglyoxal bis (guanylhydrazone) (DFMO-EGBG) and insulin/PEG-CMCS were administered to diabetic rats to explore their roles on severity of HI/RI. RESULTS: Insulin could be fleetly and efficiently loaded via the nanocarrier PEG-CMCS at pH =6, showing efficient loading and stable release. In addition, insulin/PEG-CMCS showed significant hypoglycemic activity in diabetic rats. On the other hand, ischemia/reperfusion obviously augmented the contents of creatine kinase (CK), lactic dehydrogenase (LDH), putrescine (Pu), myocardial infarct size, and NF-κB and spermidine/spermine N′-acetyltransferase (SSAT) expressions and decreased the levels of spermine (Sp), polyamine pools (PAs), heart rate (HR), coronary blood flow (CF), left ventricular developed pressure (LVDP), and ODC expression, compared with Sham. Administration of insulin and insulin/PEG-CMCS both reduced the contents of CK, LDH, Pu, myocardial infarct size, and NF-κB and SSAT expressions and increased the levels of Sp, PAs, HR, CF, LVDP, and ODC expression, while insulin/PEG-CMCS significantly indicated the protective results, and DFMO-EGBG showed the opposite effects. CONCLUSION: The research showed that insulin/PEG-CMCS could play a protective effect on HR/RI in diabetic rats via its antioxidative, antiapoptotic, and anti-inflammatory roles and modulating ODC/polyamine systems. Dove Medical Press 2018-04-23 /pmc/articles/PMC5922236/ /pubmed/29719397 http://dx.doi.org/10.2147/IJN.S160848 Text en © 2018 Tong et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Tong, Fei
Liu, Suhuan
Yan, Bing
Li, Xuejun
Ruan, Shiwei
Yang, Shuyu
Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus
title Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus
title_full Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus
title_fullStr Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus
title_full_unstemmed Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus
title_short Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus
title_sort endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/peg-cmcs preconditioning against heart ischemia/reperfusion injury in diabetes mellitus
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922236/
https://www.ncbi.nlm.nih.gov/pubmed/29719397
http://dx.doi.org/10.2147/IJN.S160848
work_keys_str_mv AT tongfei endogenousornithinedecarboxylasepolyaminesystemmediatedtheantagonistroleofinsulinpegcmcspreconditioningagainstheartischemiareperfusioninjuryindiabetesmellitus
AT liusuhuan endogenousornithinedecarboxylasepolyaminesystemmediatedtheantagonistroleofinsulinpegcmcspreconditioningagainstheartischemiareperfusioninjuryindiabetesmellitus
AT yanbing endogenousornithinedecarboxylasepolyaminesystemmediatedtheantagonistroleofinsulinpegcmcspreconditioningagainstheartischemiareperfusioninjuryindiabetesmellitus
AT lixuejun endogenousornithinedecarboxylasepolyaminesystemmediatedtheantagonistroleofinsulinpegcmcspreconditioningagainstheartischemiareperfusioninjuryindiabetesmellitus
AT ruanshiwei endogenousornithinedecarboxylasepolyaminesystemmediatedtheantagonistroleofinsulinpegcmcspreconditioningagainstheartischemiareperfusioninjuryindiabetesmellitus
AT yangshuyu endogenousornithinedecarboxylasepolyaminesystemmediatedtheantagonistroleofinsulinpegcmcspreconditioningagainstheartischemiareperfusioninjuryindiabetesmellitus